20 September 2019
Visiongain has launched a new pharma report Global Diagnostic Imaging Market Forecast: MRI Systems, Ultrasound Imaging Systems, CT Scanners, Nuclear Imaging, X-Ray Imaging, Mammography, Cardiology, Gynecology/Obs, Orthopaedics & Musculoskeletal, Radiology, Neurology & Spine, General Imaging, Hospitals, Diagnostic Imaging Centers.
Diagnostic imaging is an integral part of treatment decisions and also plays a role in therapy planning, therapy monitoring and follow-up.
The lead analyst of the report commented "Diagnostic imaging technology such as MRI and CT scans has become more precise and accessible, due to which radiology has increasingly become a key foundation of modern medicine. Currently, many of the diagnostic imaging devices are powered by artificial intelligence and machine learning. This would significantly improve diagnostic quality, efficiency, and treatment patterns.
The high cost associated with the clinical trials and development of diagnostic imaging devices coupled with the inefficient infrastructure is likely to impede the growth of the diagnostic imaging market."
Leading companies featured in the report include Canon, Inc., Carestream Health, Inc., Esaote SPA, FUJIFILM Holdings Corporation, GE Healthcare, Hitachi, Ltd., Koninklijke Philips N.V. (Royal Philips), Samsung Electronics Co., Ltd., Shimadzu Corporation, Siemens Healthineers AG and other companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to firstname.lastname@example.org or call her on +44 (0) 20 7549 9987.
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
21 July 2021
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
20 July 2021
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.
14 July 2021
Digital innovation in clinical trials and renewed focus on home production will ensure a high growth market for supply chain optimisation.